4//SEC Filing
Hoberman Kenneth 4
Accession 0001104659-20-022140
CIK 0001264587other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 9:29 PM ET
Size
4.8 KB
Accession
0001104659-20-022140
Insider Transaction Report
Form 4
Hoberman Kenneth
Chief Operating Officer
Transactions
- Award
Common Stock
2020-02-10+208,417→ 809,502 total
Footnotes (2)
- [F1]The 208,417 restricted shares will vest in three installments as follows: 69,473 shares on April 14, 2021; 69,472 shares on March 30, 2022; and 69,472 shares on January 18, 2023.
- [F2]Of the listed shares, 445,724 shares are restricted stock.
Documents
Issuer
STEMLINE THERAPEUTICS INC
CIK 0001264587
Entity typeother
Related Parties
1- filerCIK 0001573722
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 9:29 PM ET
- Size
- 4.8 KB